EYES - Second Sight Medical files for $250 million mixed securities shelf offering
Photo by smirart/iStock via Getty Images Second Sight Medical Products (EYES) has filed for a prospectus to issue $250M worth of securities in a mixed shelf offering. The company shares have lost ~3.6% in the pre-market. Second Sight Medical have more than tripled in value so far this year. Last week, the company announced that it has regained compliance with NASDAQ annual meeting requirements for continued listing on the exchange. It currently engages in a legal battle with Pixium Vision in connection with an alleged violation of an agreement between the two parties. In a lawsuit filed in the Commercial Court of Paris, the France-based company expects damages to the tune of $6.3M (€5.2M). Seeking Alpha contributor, Gold Panda has a very bearish view on Second Sight Medical noting among other things that the company shares have climbed thanks to significant retail investor interest.
For further details see:
Second Sight Medical files for $250 million mixed securities shelf offering